EUVIMEDOpdag EUVIMED
Editorial

Are Three Lung Function Risk Markers Better Than One?

Rosa Faner iD

Respirology · 2026-11 · 31 (11) · 1060-1061

DOI: 10.1002/resp.70313 ↗

At a glance

Editorial in Respirology, published online on 2026-09-20. Written by Rosa Faner. Institution: Biomedicine Department, University of Barcelona, Barcelona, Spain. 11 references. Funded by: Instituto de Salud Carlos III, Fondos FEDER una manera de hacer Europa, Institució Catalana de Recerca i Estudis Avançats.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

COPDairflow limitationlung functionsmall airway dysfunction

Authors and institutions

  • Biomedicine Department, University of Barcelona, Barcelona, Spain.
  • Fundació Clínic per la Recerca Biomèdica (FCRB) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain.

ORCID profiles: Rosa Faner

Funding

  • Instituto de Salud Carlos III
  • Fondos FEDER una manera de hacer Europa
  • Institució Catalana de Recerca i Estudis Avançats
  • European Research Council

Cite

APA

Faner, R. (2026). Are Three Lung Function Risk Markers Better Than One?. Respirology, 31(11), 1060-1061. https://doi.org/10.1002/resp.70313

Vancouver

Faner R. Are Three Lung Function Risk Markers Better Than One?. Respirology. 2026;31(11):1060-1061. doi:10.1002/resp.70313

BibTeX
@article{Faner2026,
  author = {Faner, Rosa},
  title = {Are Three Lung Function Risk Markers Better Than One?},
  journal = {Respirology},
  year = {2026},
  volume = {31},
  number = {11},
  pages = {1060--1061},
  doi = {10.1002/resp.70313}
}
Start for free →